Clinical Trials Browser

Phase 3 × NETWORK × Behavior Therapy × Clear all

NCT01503632 2025-09-22

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

Phase 3 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma